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Introduction
Critical Limb Ischemia (CLI) is the most severe form of
peripheral arterial disease. It is a highly prevalent condi-
tion with suboptimal therapeutic options. One third of
CLI patients are not suitable for surgical revascularization
- these ‘no-option’ patients have substantial morbidity and
mortality and frequently have diabetes mellitus. Hence,
new treatments are urgently required. Mesenchymal Stem
Cells (MSCs) are a novel and exciting potential for indu-
cing therapeutic angiogenesis. However, MSCs are hetero-
geneous in nature and the angiogenic potential of different
clonal populations from the same donor is currently
unknown. We hypothesize that MSC heterogeneity will
allow for the isolation of clonal cell populations with
enhanced angiogenic potential. These populations may
have enhanced therapeutic potential and may also be of
interest in exploring the mechanism of MSC-induced
angiogenesis.
Methods
The angiogenic potential of three daughter clones and the
parent clone from a single donor were determined. Firstly,
in vitro angiogenesis assay was performed. Next, the
endothelial differentiation ability of these clones was
assessed. Finally, the nature of angiogenic products in the
secretome was assessed by performing an antibody array
analysis on the conditioned media collected from each
clone.
Results
Daughter clone 1 and 2, as compared to the parent and
daughter clone 3, were highly angiogenic demonstrating
the existence of clonal heterogeneity. We next went on to
examine the ability of these clones to undergo endothelial
differentiation and observed that these two clones also
showed significant endothelial differentiation capability
which was greater with clone 1. Clone 1 which has the
greatest angiogenic and endothelial differentiation capacity
secreted the greatest quantity of angiogenic factors.
Conclusions
MSC clones derived from a single human donor are highly
angiogenic but individual clones vary in their angiogenic
potential. This study suggests that therapeutic efficacy of
MSC populations in ischemic states may be enhanced by
the use of angiogenic clones.
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